Used as a key intermediate in the synthesis of pharmaceuticals, particularly in the development of central nervous system (CNS) agents. It serves as a building block for drugs targeting neurological disorders such as Parkinson’s disease and schizophrenia due to its structural similarity to dopamine receptor ligands. Also employed in the preparation of peptidomimetic compounds, helping enhance metabolic stability and bioavailability in drug design. Its derivatives are explored in medicinal chemistry for their potential as enzyme inhibitors and receptor modulators.